rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2010-5-21
|
pubmed:abstractText |
Specific tumour suppressor genes with promoter methylation in ovarian clear cell adenocarcinoma (OCCA) can be one important epigenetic mark distinguishing OCCA from ovarian serous adenocarcinoma (OSA), benign endometriotic cysts and normal ovarian epitheliums.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1365-2362
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
310-8
|
pubmed:meshHeading |
pubmed-meshheading:20486992-Adenocarcinoma, Clear Cell,
pubmed-meshheading:20486992-Adult,
pubmed-meshheading:20486992-Aged,
pubmed-meshheading:20486992-DNA Methylation,
pubmed-meshheading:20486992-Eye Proteins,
pubmed-meshheading:20486992-Female,
pubmed-meshheading:20486992-Gene Expression,
pubmed-meshheading:20486992-Humans,
pubmed-meshheading:20486992-Membrane Proteins,
pubmed-meshheading:20486992-Middle Aged,
pubmed-meshheading:20486992-Ovarian Neoplasms,
pubmed-meshheading:20486992-Polymerase Chain Reaction,
pubmed-meshheading:20486992-Promoter Regions, Genetic,
pubmed-meshheading:20486992-Risk Factors,
pubmed-meshheading:20486992-Survival Rate,
pubmed-meshheading:20486992-Tumor Markers, Biological
|
pubmed:year |
2010
|
pubmed:articleTitle |
Promoter methylation of sFRP5 in patients with ovarian clear cell adenocarcinoma.
|
pubmed:affiliation |
Cathay General Hospital, Taipei, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|